|
Antibody
Investigational
Unknown
Unknown
Colonic Neoplasms; Epstein-Barr Virus Infections; Liposarcoma; Mouth Neoplasms; Thrombosis; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colorectal Neoplasms; Gestational Trophoblastic Disease; Granuloma, Lethal Midline; Head and Neck Neoplasms; Histiocytoma, Malignant Fibrous; Hypopharyngeal Neoplasms; Liver Neoplasms; Lung Neoplasms; Mesothelioma; Ovarian Neoplasms; Pancreatic Neoplasms; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Thyroid Neoplasms; Uterine Cervical Neoplasms; Adenocarcinoma; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Esophageal Neoplasms; Hodgkin Disease; Lymphoma; Melanoma; Nasopharyngeal Neoplasms; Small Cell Lung Carcinoma; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Nasopharyngeal Carcinoma; Neoplasms
Programmed cell death protein 1 antagonist
|
